However, inhibiting CCR6 will also affect the recruitment of other anti-tumor cells or lead to the onset of autoimmune diseases in vivo because Tregs are also recruited to other tissues by CCR6 to play an immunosuppressive role (142). Here, CCR6 is linked to autoimmune disease.